Education
About Us
Working with TipRanks
Follow Us
Enveric Biosciences (ENVB)
NASDAQ:ENVB
Total Valuation
Enveric Biosciences has a market cap or net worth of $3.91M. The enterprise value is -$1.36M.
Market Cap$3.91M
Enterprise Value-$1.36M
Share Statistics
Enveric Biosciences has 1,023,368 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,023,368
Owned by Insiders40.26%
Owned by Institutions―
Financial Efficiency
Enveric Biosciences’s return on equity (ROE) is -6.01 and return on invested capital (ROIC) is -604.74%.
Return on Equity (ROE)-6.01
Return on Assets (ROA)-3.11
Return on Invested Capital (ROIC)-604.74%
Return on Capital Employed (ROCE)-6.05
Revenue Per Employee0.00
Profits Per Employee-1.91M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Enveric Biosciences is ―. Enveric Biosciences’s PEG ratio is -0.00209.
PE Ratio―
PS Ratio0.00
PB Ratio1.70
Price to Fair Value1.70
Price to FCF-0.35
Price to Operating Cash Flow-0.15
PEG Ratio-0.00209
Income Statement
In the last 12 months, Enveric Biosciences had revenue of 0.00 and earned -9.57M in profits. Earnings per share was -228.48.
Revenue0.00
Gross Profit-337.49K
Operating Income-9.63M
Pretax Income-9.57M
Net Income-9.57M
EBITDA-9.23M
Earnings Per Share (EPS)-228.48
Cash Flow
In the last 12 months, operating cash flow was -7.67M and capital expenditures 0.00, giving a free cash flow of -7.67M billion.
Operating Cash Flow-7.67M
Free Cash Flow-7.67M
Free Cash Flow per Share-7.49
Dividends & Yields
Enveric Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.80
52-Week Price Change-94.31%
50-Day Moving Average5.38
200-Day Moving Average11.30
Relative Strength Index (RSI)39.42
Average Volume (3m)781.31K
Important Dates
Enveric Biosciences upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).
Last Earnings DateNov 14, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Enveric Biosciences as a current ratio of 1.84, with Debt / Equity ratio of 0.00%
Current Ratio1.84
Quick Ratio1.84
Debt to Market Cap0.00
Net Debt to EBITDA0.24
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Enveric Biosciences has paid 8.93K in taxes.
Income Tax8.93K
Effective Tax Rate>-0.01
Enterprise Valuation
Enveric Biosciences EV to EBITDA ratio is -0.05, with an EV/FCF ratio of -0.06.
EV to Sales0.00
EV to EBITDA-0.05
EV to Free Cash Flow-0.06
EV to Operating Cash Flow-0.06
Balance Sheet
Enveric Biosciences has $3.76M in cash and marketable securities with $0.00 in debt, giving a net cash position of $3.76M billion.
Cash & Marketable Securities$3.76M
Total Debt$0.00
Net Cash$3.76M
Net Cash Per Share$3.67
Tangible Book Value Per Share$37.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Enveric Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast79.45%